CIBC Capital Partners is a Toronto-based investment firm specializing in direct, fund, and mezzanine investments. It provides subordinated debt and equity to mid- and late-stage private or public companies for growth financing, acquisitions, management buyouts, and recapitalizations. The firm prefers investments in later-stage companies undergoing financial restructurings, with a focus on sectors such as Industrials, Healthcare, Biotechnology, Financials, and Technology. It typically invests CAD10-20 million ($9.81-$19.61 million) per company, based primarily in Canada, Europe, and Australia.

European Bank for Reconstruction and Development finances projects and provides advisory services to the public and private sectors. It supports new ventures and expansion in existing companies through project financing, loans, and equity or quasi-equity investments, including equity funds and guarantees, and it partners with private entities to invest across sectors such as banking, energy, manufacturing, infrastructure, information technology, and services. The bank also helps publicly owned entities privatize and restructure municipal services and engages in policy reform dialogue and advisory services, along with trade finance and loan syndication. Founded in 1990 and headquartered in London, it operates across regions including Southeastern and Central Europe, the Baltic States, Eastern Europe and the Caucasus, Central Asia, and parts of the Middle East and Africa, aiming to foster market-oriented change and private sector development by mobilizing capital for sustainable investments. It has invested more than €130 billion in over 5,200 projects.

Vivo Capital, LLC is a private equity and venture capital firm specializing in incubation, growth capital, early stage, mid venture, late stage, seed, startup, mezzanine, buyout, public equity, privatizations, spin-off, small to mid-cap public companies, PIPE investments in private and public companies, follow-on financings, private placements, initial public offerings, secondaries, ATM purchases and block trades. The firm seeks to invest in all financing stages from Series A to public companies. It primarily invests in healthcare including healthcare services, biotechnology, specialty pharmaceuticals, bio-pharmaceutical and bio-medical, drugs, vaccines, medical equipment, medical and health services, medicine, vaccines, medical appliances and life science companies. The firm also seeks to invest in companies with later-stage therapeutic products in clinical development. It typically makes investments in Europe, Sino-US region, China with a focus on Chengdu, North America, United States and Asia Pacific based companies with a focus on later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China also invest in companies outside the United States and Asia/Pacific. The firm seeks to invest between $2 million to $40 million. The firm prefers minority equity investments to control and majority transactions. Vivo Capital, LLC was founded in 1996 and is based in Palo Alto, California with additional offices in Beijing, China; Shanghai, China; Hong Kong, Hong Kong and Taipei, Taiwan.

Founded in 1996, Vivo Capital is a global investment firm focused on healthcare. With approximately $5.8 billion in assets under management and investments in over 290 public and private companies worldwide, the firm operates from Palo Alto, California, with additional offices in Asia. Its team comprises 50 multidisciplinary professionals, including physicians, scientists, entrepreneurs, operating executives, and industry experts. Vivo Capital invests across various healthcare sectors such as biotechnology, pharmaceuticals, medical devices, and healthcare services.

Avrio Capital Inc. is a venture capital and private equity investment firm based in Alberta, Canada, with additional offices in Ontario and Quebec. Established in 2006, the firm specializes in investing in commercialization to growth-stage companies, focusing on later-stage, early-stage, mid-venture, middle-market, and emerging growth businesses. Avrio Capital targets companies in sectors such as food technology, advanced agriculture, industrial bioproducts, and nutraceutical ingredients, particularly those addressing global challenges in health, wellness, and sustainability. The firm typically invests between CAD $1 million and CAD $10 million in companies with sales values ranging from CAD $1 million to CAD $20 million, reserving significant capital for future financing rounds. Avrio Capital takes an active role in its investments, aiming to support the long-term growth of its portfolio companies throughout their development.

SFC Capital is a United Kingdom based venture capital firm founded in 2012 that focuses on early-stage investments, including pre-seed and seed rounds, in sectors such as software, technology, e-commerce, consumer products, enterprise solutions, green technology, medical technology, and hospitality. It backs UK startups through an Angel Network and seed funds, providing capital and guidance and offering access to SEIS- and EIS-qualifying investment opportunities. The firm is described as a leading seed investor in the UK.

Enabling Future is a family office-backed venture capital firm headquartered in Dubai, United Arab Emirates. The firm focuses on seed and early-stage investments across a diverse range of sectors, including consumer goods and services, data and enterprise technology, blockchain infrastructure, fintech, and gaming. Enabling Future aims to support entrepreneurs who seek to disrupt traditional markets and innovate for the future. To achieve this, the firm provides its portfolio companies with essential resources such as capital, strategic guidance, and access to a robust network, facilitating their growth and development in an ever-evolving business landscape.

VenturesOne, established in 1986 and based in The Hague and Singapore, is a venture capital investment firm that focuses on scaling high-growth, emerging technology ventures. The company provides capital, expertise, and access to international networks to help entrepreneurs transform their ideas into successful global enterprises. VenturesOne typically invests between €100,000 and €3 million in growth-stage companies over a timeline of three to seven years. Its investment portfolio encompasses a range of emerging technologies, including adtech, artificial intelligence, machine learning, big data, cleantech, cybersecurity, e-commerce, edtech, fintech, health tech, insurtech, robotics, drones, and software as a service (SaaS). In February 2021, VenturesOne was acquired by Unknown Group.